Robert J. Lefkowitz MD
Insider Reports History
- Location
- Durham, NC
- Signature
- /s/ Robert J. Lefkowitz
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Robert J. Lefkowitz MD:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. | Director | Common Stock | 48,364 | $126,714 | $2.62 | 28 Apr 2024 | Direct |
| LEXICON PHARMACEUTICALS, INC. | Director | Restricted Stock Units | 36,810 | $96,442 | $2.62 | 13 May 2024 | Direct |
| LEXICON PHARMACEUTICALS, INC. | Director | Stock Option (Right to Buy) | 44,906 | 13 May 2024 | Direct |
Insider Reports Filed by Robert J. Lefkowitz MD
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LXRX | LEXICON PHARMACEUTICALS, INC. | 13 May 2024 | 2 | $0 | 4 | Director | 13 May 2024, 16:03 |
| LXRX | LEXICON PHARMACEUTICALS, INC. | 28 Apr 2024 | 2 | $0 | 4 | Director | 29 Apr 2024, 16:18 |
| LXRX | LEXICON PHARMACEUTICALS, INC. | 21 May 2023 | 2 | $0 | 4 | Director | 22 May 2023, 16:04 |
| LXRX | LEXICON PHARMACEUTICALS, INC. | 28 Apr 2023 | 2 | $0 | 4 | Director | 28 Apr 2023, 16:23 |
| LXRX | LEXICON PHARMACEUTICALS, INC. | 21 May 2022 | 2 | $0 | 4 | Director | 23 May 2022, 16:14 |
| LXRX | LEXICON PHARMACEUTICALS, INC. | 30 Apr 2022 | 2 | $0 | 4 | Director | 02 May 2022, 16:15 |